4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Incidence of, Risk Factors for, and Mortality Associated With Severe Acute Kidney Injury After Gunshot Wound

      research-article
      , MBBS, MD 1 , , , MD 2 , , MD 3 , , MD 4 , , MD 1
      JAMA Network Open
      American Medical Association

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          What is the incidence of severe acute kidney injury (SAKI) after gunshot wound (GSW) among civilians in the United States, what risk factors are associated with SAKI, and is SAKI associated with mortality?

          Findings

          In this cross-sectional study of civilians in the United States who experienced GSWs, the incidence of SAKI was 2.3%, and the incidence of SAKI requiring dialysis was 0.9%. Patients with GSW who developed SAKI were twice as likely to die as those without SAKI.

          Meaning

          In this study, SAKI was a significant complication after GSW and was associated with mortality.

          Abstract

          This cross-sectional study determines the incidence of and risk factors associated with severe acute kidney injury (AKI) and AKI requiring dialysis after gunshot wounds and the association of severe AKI and AKI requiring dialysis with mortality among civilians in the United States.

          Abstract

          Importance

          Acute kidney injury increases the risk of mortality in hospitalized patients. However, incidence of severe acute kidney injury (SAKI) and its association with mortality in civilians with gunshot wounds (GSWs) is not known.

          Objective

          To determine the incidence of and risk factors associated with SAKI and acute kidney injury requiring dialysis (AKI-D) after GSWs and the association of SAKI and AKI-D with mortality among civilians in the United States.

          Design, Setting, and Participants

          This retrospective cross-sectional study included civilians with GSW reported to the National Trauma Data Bank between July 1, 2010, and June 30, 2015. Torso GSWs were included in study; GSWs to the head were excluded. The data were analyzed between September and November 2018.

          Exposure

          Civilians with GSW.

          Main Outcomes and Measures

          Incidence of SAKI and AKI-D; association of SAKI and AKI-D with mortality.

          Results

          Most of the 64 059 civilian GSWs affected men (57 431 [89.7%]) and racial/ethnic minorities (36 205 [56.5%] African American individuals; 9681 [15.1%] Hispanic individuals). Incidence of SAKI was 2.3% (1450 of 64 059), and incidence of AKI-D was 0.9% (588 of 64 059). On multivariate analysis, SAKI was associated with older age (odds ratio [OR], 1.02; 95% CI, 1.01-1.02; P < .001), male sex (OR, 1.37; 95% CI, 1.12-1.66; P = .002), diabetes (OR, 1.55; 95% CI, 1.20-2.00; P = .001), hypertension (OR, 1.76; 95% CI, 1.46-2.11; P < .001), Glasgow Coma Scale score (OR, 0.98; 95% CI, 0.96-0.99; P = .002), sepsis (OR, 13.83; 95% CI, 11.77-16.24; P < .001), hollow viscus injury (OR, 2.31; 95% CI, 2.05-2.59; P < .001), and injury severity score (OR, 1.02; 95% CI, 1.01-1.02; P < .001); AKI-D was associated with systolic blood pressure (OR, 0.99; 95% CI, 0.99-1.00; P < .001), sepsis (OR, 1.56; 95% CI, 1.18-2.04; P = .001), and injury severity score (OR, 1.01; 95% CI, 1.01-1.02; P = .001). Mortality was significantly higher in patients with AKI-D (167 of 588 patients [28.4%]) compared with patients with SAKI (172 of 862 [20.0%]) and no SAKI or AKI-D (5521 of 62 609 [8.8%]) ( P < .001). Mortality was associated with older age (OR, 1.01; 95% CI, 1.01-1.01; P < .001), systolic blood pressure (OR, 0.997; 95% CI, 0.997-0.998; P < .001), Glasgow Coma Scale score (OR, 0.87; 95% CI, 0.87-0.88; P < .001), SAKI (OR, 2.32; 95% CI, 1.93-2.79; P < .001), AKI-D (OR, 1.46; 95% CI, 1.12-1.90; P < .001), hollow viscus injury (OR, 1.87; 95% CI, 1.76-1.98; P < .001), and higher injury severity score (OR, 1.01; 95% CI, 1.01-1.01; P < .001). After matching for variables except SAKI or AKI-D, patients with SAKI were twice as likely to die than patients without SAKI (320 of 1391 [23.0%] vs 158 of 1391 [11.4%]; P < .001).

          Conclusions and Relevance

          In this cross-sectional study, SAKI among civilians who experienced GSWs was associated with mortality.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

          The marginal effects of acute kidney injury on in-hospital mortality, length of stay (LOS), and costs have not been well described. A consecutive sample of 19,982 adults who were admitted to an urban academic medical center, including 9210 who had two or more serum creatinine (SCr) determinations, was evaluated. The presence and degree of acute kidney injury were assessed using absolute and relative increases from baseline to peak SCr concentration during hospitalization. Large increases in SCr concentration were relatively rare (e.g., >or=2.0 mg/dl in 105 [1%] patients), whereas more modest increases in SCr were common (e.g., >or=0.5 mg/dl in 1237 [13%] patients). Modest changes in SCr were significantly associated with mortality, LOS, and costs, even after adjustment for age, gender, admission International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis, severity of illness (diagnosis-related group weight), and chronic kidney disease. For example, an increase in SCr >or=0.5 mg/dl was associated with a 6.5-fold (95% confidence interval 5.0 to 8.5) increase in the odds of death, a 3.5-d increase in LOS, and nearly 7500 dollars in excess hospital costs. Acute kidney injury is associated with significantly increased mortality, LOS, and costs across a broad spectrum of conditions. Moreover, outcomes are related directly to the severity of acute kidney injury, whether characterized by nominal or percentage changes in serum creatinine.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            AKI in the ICU: definition, epidemiology, risk stratification, and outcomes.

            Acute kidney injury (AKI) has emerged as a major public health problem that affects millions of patients worldwide and leads to decreased survival and increased progression of underlying chronic kidney disease (CKD). Recent consensus criteria for definition and classification of AKI have provided more consistent estimates of AKI epidemiology. Patients, in particular those in the ICU, are dying of AKI and not just simply with AKI. Even small changes in serum creatinine concentrations are associated with a substantial increase in the risk of death. AKI is not a single disease but rather a syndrome comprising multiple clinical conditions. Outcomes from AKI depend on the underlying disease, the severity and duration of renal impairment, and the patient's renal baseline condition. The development of AKI is the consequence of complex interactions between the actual insult and subsequent activation of inflammation and coagulation. Contrary to the conventional view, recent experimental and clinical data argue against renal ischemia-reperfusion as a sine qua non condition for the development of AKI. Loss of renal function can occur without histological signs of tubular damage or even necrosis. The detrimental effects of AKI are not limited to classical well-known symptoms such as fluid overload and electrolyte abnormalities. AKI can also lead to problems that are not readily appreciated at the bedside and can extend well beyond the ICU stay, including progression of CKD and impaired innate immunity. Experimental and small observational studies provide evidence that AKI impairs (innate) immunity and is associated with higher infection rates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.

              Administrative and claims databases may be useful for the study of acute renal failure (ARF) and ARF that requires dialysis (ARF-D), but the validity of the corresponding diagnosis and procedure codes is unknown. The performance characteristics of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for ARF were assessed against serum creatinine-based definitions of ARF in 97,705 adult discharges from three Boston hospitals in 2004. For ARF-D, ICD-9-CM codes were compared with review of medical records in 150 patients with ARF-D and 150 control patients. As compared with a diagnostic standard of a 100% change in serum creatinine, ICD-9-CM codes for ARF had a sensitivity of 35.4%, specificity of 97.7%, positive predictive value of 47.9%, and negative predictive value of 96.1%. As compared with review of medical records, ICD-9-CM codes for ARF-D had positive predictive value of 94.0% and negative predictive value of 90.0%. It is concluded that administrative databases may be a powerful tool for the study of ARF, although the low sensitivity of ARF codes is an important caveat. The excellent performance characteristics of ICD-9-CM codes for ARF-D suggest that administrative data sets may be particularly well suited for research endeavors that involve patients with ARF-D.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                11 December 2019
                December 2019
                11 December 2019
                : 2
                : 12
                : e1917254
                Affiliations
                [1 ]Division of Nephrology, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois
                [2 ]Chang Gung Memorial Hospital, Department of Trauma and Emergency Surgery, Chang Gung University, Taoyuan City, Taiwan
                [3 ]Cook County Trauma and Burns Unit, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois
                [4 ]Division of Trauma, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois
                Author notes
                Article Information
                Accepted for Publication: October 20, 2019.
                Published: December 11, 2019. doi:10.1001/jamanetworkopen.2019.17254
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2019 Athavale AM et al. JAMA Network Open.
                Corresponding Author: Ambarish M. Athavale, MBBS, MD, Division of Nephrology, John H. Stroger Jr Hospital of Cook County, 1950 W Polk St, Chicago, IL 60612 ( aathavale@ 123456cookcountyhhs.org ).
                Author Contributions: Drs Athavale and Fu had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: All authors.
                Acquisition, analysis, or interpretation of data: Fu, Bokhari, Bajani.
                Drafting of the manuscript: Athavale, Bokhari, Bajani, Hart.
                Critical revision of the manuscript for important intellectual content: All authors.
                Statistical analysis: Fu, Bajani.
                Administrative, technical, or material support: Athavale, Bokhari.
                Supervision: Athavale, Bokhari, Hart.
                Conflict of Interest Disclosures: Dr Athavale reported serving as the site principal investigator for the National Institutes of Health–funded Nephrotic Syndrome Study Network and for the Omeros-funded ARTEMIS-IGAN trial outside the submitted work and belonging to the American Society of Nephrology and National Kidney Foundation of Illinois. No other disclosures were reported.
                Article
                zoi190653
                10.1001/jamanetworkopen.2019.17254
                6991197
                31825505
                6818f11c-51b5-49fa-981d-1dfff2c7ad46
                Copyright 2019 Athavale AM et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 18 June 2019
                : 20 October 2019
                Categories
                Research
                Original Investigation
                Online Only
                Emergency Medicine

                Comments

                Comment on this article